24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Microbiome-based interventions to modulate gut ecology and the immune system

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The gut microbiome lies at the intersection between the environment and the host, with the ability to modify host responses to disease-relevant exposures and stimuli. This is evident in how enteric microbes interact with the immune system, e.g., supporting immune maturation in early life, affecting drug efficacy via modulation of immune responses, or influencing development of immune cell populations and their mediators. Many factors modulate gut ecosystem dynamics during daily life and we are just beginning to realise the therapeutic and prophylactic potential of microbiome-based interventions. These approaches vary in application, goal, and mechanisms of action. Some modify the entire community, such as nutritional approaches or faecal microbiota transplantation, while others, such as phage therapy, probiotics, and prebiotics, target specific taxa or strains. In this review, we assessed the experimental evidence for microbiome-based interventions, with a particular focus on their clinical relevance, ecological effects, and modulation of the immune system.

          Related collections

          Most cited references308

          • Record: found
          • Abstract: found
          • Article: not found

          An obesity-associated gut microbiome with increased capacity for energy harvest.

          The worldwide obesity epidemic is stimulating efforts to identify host and environmental factors that affect energy balance. Comparisons of the distal gut microbiota of genetically obese mice and their lean littermates, as well as those of obese and lean human volunteers have revealed that obesity is associated with changes in the relative abundance of the two dominant bacterial divisions, the Bacteroidetes and the Firmicutes. Here we demonstrate through metagenomic and biochemical analyses that these changes affect the metabolic potential of the mouse gut microbiota. Our results indicate that the obese microbiome has an increased capacity to harvest energy from the diet. Furthermore, this trait is transmissible: colonization of germ-free mice with an 'obese microbiota' results in a significantly greater increase in total body fat than colonization with a 'lean microbiota'. These results identify the gut microbiota as an additional contributing factor to the pathophysiology of obesity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

            An expert panel was convened in October 2013 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) to discuss the field of probiotics. It is now 13 years since the definition of probiotics and 12 years after guidelines were published for regulators, scientists and industry by the Food and Agriculture Organization of the United Nations and the WHO (FAO/WHO). The FAO/WHO definition of a probiotic--"live microorganisms which when administered in adequate amounts confer a health benefit on the host"--was reinforced as relevant and sufficiently accommodating for current and anticipated applications. However, inconsistencies between the FAO/WHO Expert Consultation Report and the FAO/WHO Guidelines were clarified to take into account advances in science and applications. A more precise use of the term 'probiotic' will be useful to guide clinicians and consumers in differentiating the diverse products on the market. This document represents the conclusions of the ISAPP consensus meeting on the appropriate use and scope of the term probiotic.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              A human gut microbial gene catalogue established by metagenomic sequencing.

              To understand the impact of gut microbes on human health and well-being it is crucial to assess their genetic potential. Here we describe the Illumina-based metagenomic sequencing, assembly and characterization of 3.3 million non-redundant microbial genes, derived from 576.7 gigabases of sequence, from faecal samples of 124 European individuals. The gene set, approximately 150 times larger than the human gene complement, contains an overwhelming majority of the prevalent (more frequent) microbial genes of the cohort and probably includes a large proportion of the prevalent human intestinal microbial genes. The genes are largely shared among individuals of the cohort. Over 99% of the genes are bacterial, indicating that the entire cohort harbours between 1,000 and 1,150 prevalent bacterial species and each individual at least 160 such species, which are also largely shared. We define and describe the minimal gut metagenome and the minimal gut bacterial genome in terms of functions present in all individuals and most bacteria, respectively.
                Bookmark

                Author and article information

                Contributors
                tclavel@ukaachen.de
                Journal
                Mucosal Immunol
                Mucosal Immunol
                Mucosal Immunology
                Nature Publishing Group US (New York )
                1933-0219
                1935-3456
                30 September 2022
                30 September 2022
                2022
                : 15
                : 6
                : 1095-1113
                Affiliations
                [1 ]GRID grid.412301.5, ISNI 0000 0000 8653 1507, Functional Microbiome Research Group, Institute of Medical Microbiology, , University Hospital of RWTH Aachen, ; Aachen, Germany
                [2 ]GRID grid.40368.39, ISNI 0000 0000 9347 0159, Gut Microbes & Health, , Quadram Institute Biosciences, ; Norwich, UK
                [3 ]GRID grid.6936.a, ISNI 0000000123222966, Intestinal Microbiome, School of Life Sciences, ZIEL—Institute for Food & Health, , Technical University of Munich, ; Freising, Germany
                [4 ]GRID grid.8273.e, ISNI 0000 0001 1092 7967, Norwich Medical School, , University of East Anglia, ; Norwich, UK
                [5 ]GRID grid.7872.a, ISNI 0000000123318773, School of Food and Nutritional Sciences, , University College Cork, ; Cork, Ireland
                [6 ]GRID grid.7872.a, ISNI 0000000123318773, APC Microbiome Ireland, School of Microbiology and Department of Medicine, , University College Cork, ; Cork, Ireland
                [7 ]PharmaBiome AG, Zürich, Switzerland
                [8 ]GRID grid.5801.c, ISNI 0000 0001 2156 2780, Institute of Food, Nutrition and Health, Department of Health Sciences and Technology, , ETH Zürich, ; Zürich, Switzerland
                Article
                564
                10.1038/s41385-022-00564-1
                9705255
                36180583
                01e79df9-4ae0-4911-af29-4edaedcc368c
                © The Author(s) 2022

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 28 June 2022
                : 12 August 2022
                : 22 August 2022
                Categories
                Review Article
                Custom metadata
                © Society for Mucosal Immunology 2022

                Immunology
                Immunology

                Comments

                Comment on this article